BPC-157 10mg / GHK-Cu 50mg / TB-500 10mg /KPV 10mg 80mg

Combination research blend of BPC-157, GHK-Cu, and TB-500 (Thymosin Beta-4 fragment). Studied in tissue-repair and regeneration research models. Lyophilized powder. Reconstitute with bacteriostatic water for in-vitro research. Store at -20°C. Certificate of Analysis attached to this listing.

—

The KLOW peptide blend combines four peptides: GHK-Cu, KPV, BPC-157, and TB-500, each contributing unique mechanisms to the overall function of the stack. GHK-Cu is a copper-binding peptide that has been shown to modulate over 4,000 human genes, promoting skin and connective tissue repair. It enhances collagen and elastin synthesis, which are critical for structural integrity and skin rejuvenation (Pickart and Margolina, International Journal of Molecular Sciences, 2018).

KPV, a tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH), primarily targets anti-inflammatory pathways. It has been documented to inhibit NF-κB activation in intestinal epithelial cells, which is crucial for reducing inflammation. A study by Dalmasso et al. (Gastroenterology, 2008) demonstrated KPV's ability to be transported into colonic cells via PepT1, contributing to its anti-inflammatory effects.

BPC-157 and TB-500 also exhibit anti-inflammatory properties, but these are secondary to their primary roles in tissue repair. BPC-157 is known for its regenerative effects on tendons, ligaments, and muscles, while TB-500 promotes cell migration and new blood vessel formation, which are essential for healing processes. However, both BPC-157 and TB-500's anti-inflammatory effects are not as direct as KPV's.

The rationale for combining these peptides lies in their complementary mechanisms. While GHK-Cu, BPC-157, and TB-500 focus on structural repair and regeneration, KPV adds a targeted approach to managing inflammation, making the KLOW stack particularly appealing for research contexts involving chronic inflammation or autoimmune conditions. It is important to note that no published study has validated the synergistic effects of this combination, and the reasoning is based on community-derived insights rather than direct evidence of their combined efficacy. [Source: Peptide Dosing Protocols — klow-stack]

Teton Labs product catalog · research-use compound data.